11/21/2003 Geneva Prevails As U.S. District Court Upholds Augmentin(R) Patents' Invalidation Geneva Pharmaceuticals, Inc. ("Geneva"), an affiliate of Novartis AG, is pleased to announce that today, the Court of Appeals for the Federal Circuit affirmed the U.S. District Court for the Eastern D... Source: Geneva Pharmaceuticals, Inc.
	11/20/2003 Sterilox Receives U.S. Patent For Disinfectant System Sterilox Technologies, Inc. today announced that its UK subsidiary Sterilox Medical (Europe) Limited received U.S. Patent No. 6,632,347 B1 for its proprietary method for operating an electrochemical c... Source: Sterilox Technologies, Inc.
	11/20/2003 ADVR's AVR118 Granted A Patent In China For The Treatment Of AIDS Advanced Viral Research Corp. (BULLETIN BOARD: ADVR) today announced that China has recently granted the Company a patent for the treatment of AIDS patients with AVR118 (formerly known as Product R)... Source: Advanced Viral Research Corp.
	11/20/2003 Genaera Announces Patent Issued For Interleukin-9 Receptor Antibody Treatment Of Asthmatic Symptoms Genaera Corporation today announced issuance by the United States Patent and Trademark Office of patent number 6,645,492 covering claims related to treating asthmatic symptoms by administering an ant... Source: Genaera Corporation
	11/19/2003 Novogen Granted U.S. Patent Covering Phenoxodiol For Cancer Treatment Pharmaceutical company Novogen , has been granted the U.S. patent covering methods for treating all benign and malignant cancers with the anti-cancer drug phenoxodiol, including ovarian cancer, breast... Source: Novogen Limited
	11/19/2003 BodyMedia(R) Awarded Wearable Body Monitoring Patent For Health, Wellness And Fitness BodyMedia, Inc., a leading developer and provider of body monitoring applications for clinical and consumer healthcare markets, announced today, that it has been awarded United States Patent No. 6,605... Source: BodyMedia, Inc.
	11/18/2003 Oncolytics Biotech Granted Ras Targeted Herpes Virus Patent Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ("Oncolytics") announced that it has been granted U.S. Patent 6,649,157 entitled "Viruses for the Treatment of Cellular Proliferative Disorders." The c... Source: Oncolytics Biotech Inc.
	11/18/2003 Genetic Technologies Settles Lawsuits With Covance And Nuvelo Genetic Technologies Limited has reported that two out of the three law suits filed by Genetic Technologies against US biotechnology companies were settled in the United States last week.... Source: Genetic Technologies Limited
	11/18/2003 Major Biologics Manufacturers To Convene And Discuss Off-Patent Biologics Market With the enormous market sized for off-patent biopharmaceuticals reaching several billion dollars by 2004, companies are strategically defining strategies to compete for the approximately $10 billion ... Source: IBC Life Sciences
	11/17/2003 Antares Pharma Announces Notice Of Allowance For Its Patent Application Antares Pharma, Inc. (BULLETIN BOARD: ANTR) announced that it has received Notice of Allowance from the U.S. Patent and Trademark Office for a patent application on the formulation technology associ... Source: Antares Pharma, Inc.
	Previous Page | Next Page

 

				New Tech Alerts				Special Offer Alerts

Receive e-mail alerts on the latest technologies in:	Sign-up to find out about special offers on products:
Apoptosis Cell Biology & Tissue Culture PCR/RT-PCR Electrophoresis Nucleic Acid Purification Transfection Laboratory Equipment Immunochemicals Software Cloning Protein Biochemistry Bio-Services Imaging Systems Molecular Biology   Your Email Address:   HTML-Formatted Text-Only	Tissue Culture Array Technology PCR Cloning Signal Transduction Antibodies Nucelic Acid Isolation Imaging/Microscopy Laboratory Equipment Transfection Protein Expression Flow Cytometry Robotics/Automation   Your Email Address:   HTML-Formatted Text-Only